Delivery Order SPE2DB25D3012-SPE2DB25FWYUM
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count supply) valued at approximately $53.3K. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 14, 2025, awarded on July 24, 2025. The pharmaceutical product will be supplied to the federal government through AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at approximately $32,000 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of August 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Tagrisso 80 mg tablets in quantities of 30, with a ceiling value of $10,662.57. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents fulfillment of pharmaceutical needs for military and federal healthcare systems. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for Tagrisso 80 mg tablets (30-count packages). This contract utilizes firm fixed pricing with an ultimate completion date of August 11, 2025. The award was competitively awarded with no set-aside designation, and performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents a child contract under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition, reflecting the contractor's capability to meet federal procurement standards. The contract will be performed at AmerisourceBergen's corporate office...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $20,444.86 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 4561500611 TAGRISSO 40 MG TABLET 30S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 14, 2023 through August 4, 2023. No set aside designation or subcontracting details were provided. DLA manages the global...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $10,247.06 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide 4561422341 TAGRISSO 80 MG TABLET 30S. The delivery order is being carried out under an existing DLA indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to various Department of Defense entities. Performance will take place in...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $40,889.72 by the Defense Logistics Agency (DLA) to supply Tagrisso 40 mg tablets. The order was placed against an existing indefinite-delivery contract and requires delivery of the pharmaceutical product to DLA facilities in Conshohocken, Pennsylvania by November 17, 2023. No set-aside designation was applied to this award to support DLA's provision of medications and medical supplies. As a leading...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $21,077.60 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The delivery order has a completion date of February 29, 2024 and was awarded on February 7, 2024. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to...
- The Defense Logistics Agency (DLA) awarded a $21,325.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This non-set-aside contract was competitively awarded on July 24, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYUMDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for TAGRISSO 40 mg tablets (30-count packages). The contract, valued at $10,641.07, is scheduled for completion by August 13, 2025, and represents a non-competitive set-aside delivery order placed against the company's existing Indefinite Delivery Contract with DLA. This award falls under a larger $999.99 billion indefinite delivery vehicle designated SPE2DX with the DLA Troop Support Medical that runs through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The delivery of TAGRISSO, a branded oncology medication, reflects the company's extensive portfolio in supplying specialty pharmaceuticals and medical products to support military and federal healthcare systems. AmerisourceBergen Drug Corp has demonstrated its competitive capability to meet federal procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management products, and vaccines. The performance location for this order is the company's corporate office in Conshohocken, Pennsylvania, and the firm fixed-price structure provides cost certainty for this pharmaceutical delivery supporting military medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 7/23/25 |